Chimerix (NASDAQ: CMRX) reported Q2 EPS of ($0.39), $0.12 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $1.98 million.

For earnings history and earnings-related data on Chimerix (CMRX) click here.